FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

Summary
(MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...
Description from Medpagetoday.
Who is covering this
-
FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease
(MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...
-
FDA Approves Sanofi's Infilbray, First Drug to Cross Into Brain for Rare Type 3 Gaucher Disease
The FDA has approved Sanofi's oral drug Infilbray for adults and children weighing at least 15 kilograms with type 3 Gaucher disease neurological symptoms.





Comments
Comments need JavaScript.